Prospective screening for δ-hemoglobinopathies associated with decreased hemoglobin A 2 levels or hemoglobin A 2 variants: A single center experience.

MLA

Hanart, Chulikon, et al. “Prospective Screening for δ-Hemoglobinopathies Associated with Decreased Hemoglobin A 2 Levels or Hemoglobin A 2 Variants: A Single Center Experience.” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 547, July 2023, p. 117417. EBSCOhost, https://doi.org/10.1016/j.cca.2023.117417.

APA

Hanart, C., Singha, K., Changtrakul, Y., Fucharoen, S., & Srivorakun, H. (2023). Prospective screening for δ-hemoglobinopathies associated with decreased hemoglobin A 2 levels or hemoglobin A 2 variants: A single center experience. Clinica Chimica Acta; International Journal of Clinical Chemistry, 547, 117417. https://doi.org/10.1016/j.cca.2023.117417

Chicago

Hanart, Chulikon, Kritsada Singha, Yotsombat Changtrakul, Supan Fucharoen, and Hataichanok Srivorakun. 2023. “Prospective Screening for δ-Hemoglobinopathies Associated with Decreased Hemoglobin A 2 Levels or Hemoglobin A 2 Variants: A Single Center Experience.” Clinica Chimica Acta; International Journal of Clinical Chemistry 547 (July): 117417. doi:10.1016/j.cca.2023.117417.